메뉴 건너뛰기




Volumn 11, Issue 11, 2002, Pages 1519-1527

Acyl coenzyme A:cholesterol acyltransferase inhibition: Potential atherosclerosis therapy or springboard for other discoveries?

Author keywords

Acyl coenzyme A:cholesterol acyltransferase inhibition; Atherosclerosis; Cholesterol; Direct antiatherosclerotic; Lipids; Lipoproteins

Indexed keywords

1 BENZYL 1 [[3 (4 CHLOROPHENYL) 5 METHYL 2 BENZOFURANYL]METHYL] 3 (2,4,6 TRIFLUOROPHENYL)UREA; 1,3 BIS[[1 CYCLOHEPTYL 3 (4 DIMETHYLAMINOPHENYL)UREIDO]METHYL]BENZENE; 2,2 DIMETHYL N (2,4,6 TRIMETHOXYPHENYL)DODECANAMIDE; 3 (2,4 DIFLUOROPHENYL) 1 HEPTYL 1 (4 NEOPENTYLBENZYL)UREA; 3 [N (2,2,5,5 TETRAMETHYL 1,3 DIOXANE 4 CARBONYL)AMINO]PROPIONIC ACID 2 (3 NEOPENTYL 3 NONYLUREIDO)CYCLOHEXYL ESTER; ACETYL COENZYME A ACYLTRANSFERASE; ACYLTRANSFERASE INHIBITOR; ATORVASTATIN; AVASIMIBE; CHOLESTEROL; CHOLESTEROL 7ALPHA MONOOXYGENASE; CHOLESTEROL ESTER; CHYLOMICRON; CP 113818; EAB 309; EFLUCIMIBE; F 145237; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; KY 505; LIPOPROTEIN; MATRIX METALLOPROTEINASE; MELINAMIDE; MIDAZOLAM; N (2,6 DIISOPROPYLPHENYL)TETRADECYLTHIOACETAMIDE; R 755; SIMVASTATIN; TRIACYLGLYCEROL; TS 962; UNCLASSIFIED DRUG; UNINDEXED DRUG; VERY LOW DENSITY LIPOPROTEIN; YM 17 E;

EID: 0036849179     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.11.11.1519     Document Type: Review
Times cited : (17)

References (53)
  • 1
    • 0032500641 scopus 로고    scopus 로고
    • Characterization of two human genes encoding acyl coenzyme A: Cholesterol acyltransferase-related enzymes
    • OELKERS P, BEHARI A, CROMLEY D, BILLHEIMER JT, STURLEY SL: Characterization of two human genes encoding acyl coenzyme A: Cholesterol acyltransferase-related enzymes. J Biol. Chem. (1998) 273(41):26765-26771.
    • (1998) J Biol. Chem , vol.273 , Issue.41 , pp. 26765-26771
    • Oelkers, P.1    Behari, A.2    Cromley, D.3    Billheimer, J.T.4    Sturley, S.L.5
  • 2
    • 0027527733 scopus 로고
    • Molecular cloning and functional expression of human acylcoenzyme A-cholesterol acyltransferase cDNA in mutant Chinese hamster ovary cells
    • CHANG CCY, HUH HY, CADIGAN KM, CHANG TY: Molecular cloning and functional expression of human acylcoenzyme A-cholesterol acyltransferase cDNA in mutant Chinese hamster ovary cells. J. Biol. Chem. (1993) 268:20747-20755.
    • (1993) J. Biol. Chem , vol.268 , pp. 20747-20755
    • Chang, C.C.Y.1    Huh, H.Y.2    Cadigan, K.M.3    Chang, T.Y.4
  • 3
    • 0031668254 scopus 로고    scopus 로고
    • Expression of ACAT-1 protein in human atherosclerotic lesions and cultured human monocytes-macrophages
    • MIYAZAKI A, SAKASHITA N, LEE O et al. Expression of ACAT-1 protein in human atherosclerotic lesions and cultured human monocytes-macrophages. Arterioscler. Thromb. Vasc. Biol. (1998) 18(10):1568-1574.
    • (1998) Arterioscler. Thromb. Vasc. Biol , vol.18 , Issue.10 , pp. 1568-1574
    • Miyazaki, A.1    Sakashita, N.2    Lee, O.3
  • 4
    • 15444348784 scopus 로고    scopus 로고
    • ACAT-2, a second mammalian acyl-CoA:cholesterol acyltransferase - Its cloning, expression, and characterization
    • CASES S, NOVAK S, ZHENG YW et al.: ACAT-2, a second mammalian acyl-CoA:cholesterol acyltransferase - Its cloning, expression, and characterization. J. Biol. Chem. (1998) 273(41):26755-26764.
    • (1998) J. Biol. Chem , vol.273 , Issue.41 , pp. 26755-26764
    • Cases, S.1    Novak, S.2    Zheng, Y.W.3
  • 5
    • 0032500649 scopus 로고    scopus 로고
    • Identification of a form of acyl-CoA:cholesterol acyltransferase specific to liver and intestine in nonhuman primates
    • ANDERSON RA, JOYCE C, DAVIS M et al: Identification of a form of acyl-CoA:cholesterol acyltransferase specific to liver and intestine in nonhuman primates. J. Biol. Chem. (1998) 273(41):26747-26754.
    • (1998) J. Biol. Chem , vol.273 , Issue.41 , pp. 26747-26754
    • Anderson, R.A.1    Joyce, C.2    Davis, M.3
  • 6
    • 0032478235 scopus 로고    scopus 로고
    • Relationship between bioavailability and hypocholesterolemic activity of YM17E, an inhibitor of ACAT, in cholesterol-fed rats
    • UCHIDA T, AOYAMA K, WATANABE T, HIGUCHI S: Relationship between bioavailability and hypocholesterolemic activity of YM17E, an inhibitor of ACAT, in cholesterol-fed rats. Atherosclerosis (1998) 137(1):97-106.
    • (1998) Atherosclerosis , vol.137 , Issue.1 , pp. 97-106
    • Uchida, T.1    Aoyama, K.2    Watanabe, T.3    Higuchi, S.4
  • 7
    • 0345411397 scopus 로고    scopus 로고
    • A selective inhibitor of intestinal ACAT, EAB309 suppresses both intestinal and hepatic cholesterol output and stimulates chylomicron removal
    • UMEDA Y, HIRANO T, KAKO Y, KAMAGATA K, OKUYAMA K, SUZUKI K: A selective inhibitor of intestinal ACAT, EAB309 suppresses both intestinal and hepatic cholesterol output and stimulates chylomicron removal. Life Sci. (1998) 63(13):187-195.
    • (1998) Life Sci , vol.63 , Issue.13 , pp. 187-195
    • Umeda, Y.1    Hirano, T.2    Kako, Y.3    Kamagata, K.4    Okuyama, K.5    Suzuki, K.6
  • 8
    • 0011452376 scopus 로고
    • Factors facilitating cholesterol absorption from the intestine via lymphatic pathways
    • VAHOUNY GV, FAWAL I, TREADWELL CR: Factors facilitating cholesterol absorption from the intestine via lymphatic pathways. Am. J. Physiol. (1957) 188:742-746.
    • (1957) Am. J. Physiol , vol.188 , pp. 742-746
    • Vahouny, G.V.1    Fawal, I.2    Treadwell, C.R.3
  • 9
    • 0022256566 scopus 로고
    • Role of acyl-CoA-cholesterol acyl-transferase in cellular cholesterol metabolism
    • SUCKLING KE, STANGE EF: Role of acyl-CoA-cholesterol acyl-transferase in cellular cholesterol metabolism. J. Lipid Res. (1985) 26:647-671.
    • (1985) J. Lipid Res , vol.26 , pp. 647-671
    • Suckling, K.E.1    Stange, E.F.2
  • 10
    • 0021043541 scopus 로고
    • Role of acyl CoA:cholesterol acyltransferase in cholesterol absorption and its inhibition of 57-118 in the rabbit
    • HEIDER JG, PICKENS CE, KELLY LA: Role of acyl CoA:cholesterol acyltransferase in cholesterol absorption and its inhibition of 57-118 in the rabbit. J. Lipid Res. (1983) 24:1127-1134.
    • (1983) J. Lipid Res , vol.24 , pp. 1127-1134
    • Heider, J.G.1    Pickens, C.E.2    Kelly, L.A.3
  • 11
    • 0021367211 scopus 로고
    • Reduced cholesterol transmucosal transport in rats with inhibited mucosal acyl CoA:cholesterol acyltransferase and normal pancreatic function
    • BENNETT CS, TERCYAK AM: Reduced cholesterol transmucosal transport in rats with inhibited mucosal acyl CoA:cholesterol acyltransferase and normal pancreatic function. J. Lipid Res. (1984) 25:148-159.
    • (1984) J. Lipid Res , vol.25 , pp. 148-159
    • Bennett, C.S.1    Tercyak, A.M.2
  • 12
    • 0024389312 scopus 로고
    • CL277082, a novel inhibitor of ACAT-catalyzed cholesterol esterification and cholesterol absorption
    • LARGIS EE, WANG CH, DEVRIES VG, SCHAFFER SA: CL277082, a novel inhibitor of ACAT-catalyzed cholesterol esterification and cholesterol absorption. J. Lipid Res. (1989) 30:681-690.
    • (1989) J. Lipid Res , vol.30 , pp. 681-690
    • Largis, E.E.1    Wang, C.H.2    Devries, V.G.3    Schaffer, S.A.4
  • 13
    • 0031909066 scopus 로고    scopus 로고
    • Inhibition of acyl coenzyme A: Cholesterol acyltransferase blocks esterification but not uptake of cholesterol in Caco-2 cells
    • ELLSWORTH JL, STARR JR: Inhibition of acyl coenzyme A: cholesterol acyltransferase blocks esterification but not uptake of cholesterol in Caco-2 cells. Metabolism (1998) 47(3):325-332.
    • (1998) Metabolism , vol.47 , Issue.3 , pp. 325-332
    • Ellsworth, J.L.1    Starr, J.R.2
  • 14
    • 0036191526 scopus 로고    scopus 로고
    • Cholesterol esters regulate apo B48 secretion in CaCo2 cells
    • PALS S, ALLISTER E, THOMSON A, MAMO JC: Cholesterol esters regulate apo B48 secretion in CaCo2 cells. Atherosclerosis (2002) 161(1):55-63.
    • (2002) Atherosclerosis , vol.161 , Issue.1 , pp. 55-63
    • Pals, S.1    Allister, E.2    Thomson, A.3    Mamo, J.C.4
  • 15
    • 0011487723 scopus 로고    scopus 로고
    • The ACAT inhibitor avasimibe increases the fractional clearance rate of postprandial triglyceride-rich lipoproteins
    • BURNETT JR, BARRETT PHR, TELFORD DE, HUFF MW. The ACAT inhibitor avasimibe increases the fractional clearance rate of postprandial triglyceride-rich lipoproteins. Atherosclerosis (2000) 151:134.
    • (2000) Atherosclerosis , vol.151 , pp. 134
    • Burnett, J.R.1    Barrett, P.H.R.2    Telford, D.E.3    Huff, M.W.4
  • 16
    • 0036470894 scopus 로고    scopus 로고
    • Intracellular mechanisms mediating the inhibition of ApoB-containing lipoprotein synthesis and secretion in HepG2 cells by avasimibe (CI-1011), a novel acyl-coenzyme A:cholesterol acyltransferase (ACAT) inhibitor
    • TAGHIBIGLOU C, VAN IDERSTINE S, KULINSKI A, RUDY D, ADELI K: Intracellular mechanisms mediating the inhibition of ApoB-containing lipoprotein synthesis and secretion in HepG2 cells by avasimibe (CI-1011), a novel acyl-coenzyme A:cholesterol acyltransferase (ACAT) inhibitor. Biochem. Pharmacol. (2002) 63(3):349-360.
    • (2002) Biochem. Pharmacol , vol.63 , Issue.3 , pp. 349-360
    • Taghibiglou, C.1    Van Iderstine, S.2    Kulinski, A.3    Rudy, D.4    Adeli, K.5
  • 17
    • 0032769066 scopus 로고    scopus 로고
    • Inhibition of ACAT by avasimibe decreases both VLDL and LDL apolipoprotein B production in miniature pigs
    • BURNETT JR, WILCOX LJ, TELFORD DE et al: Inhibition of ACAT by avasimibe decreases both VLDL and LDL apolipoprotein B production in miniature pigs. J. Lipid Res. (1999) 40:1317-27.
    • (1999) J. Lipid Res , vol.40 , pp. 1317-1327
    • Burnett, J.R.1    Wilcox, L.J.2    Telford, D.E.3
  • 18
    • 0032918323 scopus 로고    scopus 로고
    • ApoB 100 secretion from HepG2 cells is decreased by the ACAT inhibitor CI-1011: An effect associated with enhanced intracellular degradation of apoB
    • WILCOX LJ, BARRETT PHR, NEWTON RS, HUFF MW: ApoB 100 secretion from HepG2 cells is decreased by the ACAT inhibitor CI-1011: an effect associated with enhanced intracellular degradation of apoB. Arterioscler. Thromb. Vasc. Biol. (1999) 19:939-949.
    • (1999) Arterioscler. Thromb. Vasc. Biol , vol.19 , pp. 939-949
    • Wilcox, L.J.1    Barrett, P.H.R.2    Newton, R.S.3    Huff, M.W.4
  • 19
    • 20644442234 scopus 로고    scopus 로고
    • Acyl-coenzyme A:cholesterol acyltransferase inhibitor, avasimibe, stimulates bile acid synthesis and cholesterol 7alpha-hydroxylase in cultured rat hepatocytes and in vivo in the rat
    • POST SM, ZOETEWEIJ JP, BOS MHA et al: Acyl-coenzyme A:cholesterol acyltransferase inhibitor, avasimibe, stimulates bile acid synthesis and cholesterol 7alpha-hydroxylase in cultured rat hepatocytes and in vivo in the rat. Hepatology (1999) 30(2):491-500.
    • (1999) Hepatology , vol.30 , Issue.2 , pp. 491-500
    • Post, S.M.1    Zoeteweij, J.P.2    Bos, M.H.A.3
  • 20
    • 0031668254 scopus 로고    scopus 로고
    • Expression of ACAT-1 protein in human atherosclerotic lesions and cultured human monocytes-macrophages
    • MIYAZAKI A, SAKASHITA N, LEE O et al: Expression of ACAT-1 protein in human atherosclerotic lesions and cultured human monocytes-macrophages. Arterioscler. Thromb. Vasc. Biol. (1998) 18(10):1568-1574.
    • (1998) Arterioscler. Thromb. Vasc. Biol , vol.18 , Issue.10 , pp. 1568-1574
    • Miyazaki, A.1    Sakashita, N.2    Lee, O.3
  • 21
    • 0001569096 scopus 로고    scopus 로고
    • The acyl-CoA:Cholesterol acyltransferase inhibitor, avasimibe, effectively limits lipid storage in human macrophages
    • RODRIGUEZ A, WEE SB, USHER DC: The acyl-CoA:Cholesterol acyltransferase inhibitor, avasimibe, effectively limits lipid storage in human macrophages. Circulation (1999) 100(18):I613.
    • (1999) Circulation , vol.100 , Issue.18
    • Rodriguez, A.1    Wee, S.B.2    Usher, D.C.3
  • 22
    • 0032469027 scopus 로고    scopus 로고
    • Stimulation of cholesterol release from rabbit foam cells by the action of a new inhibitor for acyl CoA:cholesterol acyltransferase (ACAT), HL-004
    • ISHII I, YOKOYAMA N, YANAGIMACHI M et al: Stimulation of cholesterol release from rabbit foam cells by the action of a new inhibitor for acyl CoA:cholesterol acyltransferase (ACAT), HL-004. J. Pharmacol. Exp. Therap. (1998) 287(1):115-121.
    • (1998) J. Pharmacol. Exp. Therap , vol.287 , Issue.1 , pp. 115-121
    • Ishii, I.1    Yokoyama, N.2    Yanagimachi, M.3
  • 23
    • 0035863037 scopus 로고    scopus 로고
    • Effects of high-density lipoprotein(2) on cholesterol transport and acyl-coenzyme A:cholesterol acyltransferase activity in P388D1 macrophages
    • LI L, POWNALL HJ: Effects of high-density lipoprotein(2) on cholesterol transport and acyl-coenzyme A:cholesterol acyltransferase activity in P388D1 macrophages. Biochem. Biophys. Acta (2001) 1530 (1):111-122.
    • (2001) Biochem. Biophys. Acta , vol.1530 , Issue.1 , pp. 111-122
    • Li, L.1    Pownall, H.J.2
  • 24
    • 0035799373 scopus 로고    scopus 로고
    • Acyl-CoA: Cholesterol acyltransferase inhibitor avasimibe reduces atherosclerosis in addition to its cholesterol-lowering effect in ApoE*3-Leiden mice
    • DELSING DJM, OFFERMAN EH, VAN DUYVENVOORDE W et al: Acyl-CoA: Cholesterol acyltransferase inhibitor avasimibe reduces atherosclerosis in addition to its cholesterol-lowering effect in ApoE*3-Leiden mice. Circulation (2001) 103:1778-1786.
    • (2001) Circulation , vol.103 , pp. 1778-1786
    • Delsing, D.J.M.1    Offerman, E.H.2    Van Duyvenvoorde, W.3
  • 25
    • 0032478324 scopus 로고    scopus 로고
    • The ACAT inhibitor, CI-1011, is effective in the prevention and regression of aortic fatty streak area in hamsters
    • NICOLOSI RJ, WILSON TA, KRAUSE BR: The ACAT inhibitor, CI-1011, is effective in the prevention and regression of aortic fatty streak area in hamsters. Atherosclerosis (1998) 137:77-85.
    • (1998) Atherosclerosis , vol.137 , pp. 77-85
    • Nicolosi, R.J.1    Wilson, T.A.2    Krause, B.R.3
  • 26
    • 0033972030 scopus 로고    scopus 로고
    • The ACAT inhibitor avasimibe reduces macrophages and matrix metalloproteinase expression in atherosclerotic lesions of hypercholesterolemic rabbits
    • BOCAN TMA, KRAUSE BR, ROSEBURY WS et al.: The ACAT inhibitor avasimibe reduces macrophages and matrix metalloproteinase expression in atherosclerotic lesions of hypercholesterolemic rabbits. Arterioscler. Thromb. Vasc. Biol. (2000) 20:70-79.
    • (2000) Arterioscler. Thromb. Vasc. Biol , vol.20 , pp. 70-79
    • Bocan, T.M.A.1    Krause, B.R.2    Rosebury, W.S.3
  • 27
    • 0034891581 scopus 로고    scopus 로고
    • Direct effect of an acyl-CoA:cholesterol acyltransferase inhibitor, F-1394, on atherosclerosis in apolipoprotein E and low density lipoprotein receptor double knockout mice
    • CHIWATA T, ARAGANE K, FUJINAMI K et al: Direct effect of an acyl-CoA:cholesterol acyltransferase inhibitor, F-1394, on atherosclerosis in apolipoprotein E and low density lipoprotein receptor double knockout mice. Br. J. Pharmacol. (2001) 133(7):1005-1012.
    • (2001) Br. J. Pharmacol , vol.133 , Issue.7 , pp. 1005-1012
    • Chiwata, T.1    Aragane, K.2    Fujinami, K.3
  • 28
    • 0035967492 scopus 로고    scopus 로고
    • Acyl-CoA-cholesterol acyltransferase inhibition reduces atherosclerosis in apolipoprotein E-deficient mice
    • KUSUNOKI J, HANSOTY DK, ARAGANE K, FALON JT, BADIMON JJ, FISHER EA: Acyl-CoA-cholesterol acyltransferase inhibition reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation (2001) 103(21):2604-2609.
    • (2001) Circulation , vol.103 , Issue.21 , pp. 2604-2609
    • Kusunoki, J.1    Hansoty, D.K.2    Aragane, K.3    Falon, J.T.4    Badimon, J.J.5    Fisher, E.A.6
  • 29
    • 0034898471 scopus 로고    scopus 로고
    • Effect of F-1394, an acyl-CoA: Cholesterol acyltransferase inhibitor, on atherosclerosis induced by high cholesterol diet in rabbits
    • ARAGANE K, KOJIMA K, FUJINAMI K, KAMEI J, KUSUNOKI J: Effect of F-1394, an acyl-CoA: cholesterol acyltransferase inhibitor, on atherosclerosis induced by high cholesterol diet in rabbits. Atherosclerosis (2001) 158(1):139-145.
    • (2001) Atherosclerosis , vol.158 , Issue.1 , pp. 139-145
    • Aragane, K.1    Kojima, K.2    Fujinami, K.3    Kamei, J.4    Kusunoki, J.5
  • 30
    • 0035063279 scopus 로고    scopus 로고
    • ACAT inhibitor F-1394 prevents intimal hyperplasia induced by balloon injury in rabbits
    • ARAGANE K, FUJINAMI K, KOJIMA K, KUSUNOKI J: ACAT inhibitor F-1394 prevents intimal hyperplasia induced by balloon injury in rabbits. J. Lipid Res. (2001) 42(2):480-488.
    • (2001) J. Lipid Res , vol.42 , Issue.2 , pp. 480-488
    • Aragane, K.1    Fujinami, K.2    Kojima, K.3    Kusunoki, J.4
  • 31
    • 0035004680 scopus 로고    scopus 로고
    • Pharmacological properties of R-755, a novel acyl-CoA:cholesterol acyltransferase inhibitor, in cholesterol-fed rats, hamsters and rabbits
    • MATSUI Y. HORIUCHI K, YAMAMOTO K, KANAI K: Pharmacological properties of R-755, a novel acyl-CoA:cholesterol acyltransferase inhibitor, in cholesterol-fed rats, hamsters and rabbits. Jpn. J. Pharmacol. (2001) 5(4):423-433.
    • (2001) Jpn. J. Pharmacol , vol.5 , Issue.4 , pp. 423-433
    • Matsui, Y.1    Horiuchi, K.2    Yamamoto, K.3    Kanai, K.4
  • 32
    • 0011395198 scopus 로고    scopus 로고
    • The effect of ACAT inhibition with avasimibe on vascular function in hypercholesterolemia
    • KURZ S, BORTHAYRE AB, HARRISON DG: The effect of ACAT inhibition with avasimibe on vascular function in hypercholesterolemia. Circulation (1998):I109-I110.
    • (1998) Circulation
    • Kurz, S.1    Borthayre, A.B.2    Harrison, D.G.3
  • 33
    • 0032080223 scopus 로고    scopus 로고
    • Immunolocalization of acyl-coenzyme A: Cholesterol O-acyltransferase in macrophages
    • KHELEF N, BUTON X, BEATINI N et al: Immunolocalization of acyl-coenzyme A: Cholesterol O-acyltransferase in macrophages. J. Biol. Chem. (1998) 273(18):11218-11224.
    • (1998) J. Biol. Chem , vol.273 , Issue.18 , pp. 11218-11224
    • Khelef, N.1    Buton, X.2    Beatini, N.3
  • 34
    • 0036150483 scopus 로고    scopus 로고
    • Anti-atherosclerotic properties of the acyl-coenzyme A:cholesterol acyltransferase inhibitor F 12511 in casein-fed New Zealand rabbits
    • RIVAL Y, JUNQUERO D, BRUNIQUEL F et al.: Anti-atherosclerotic properties of the acyl-coenzyme A:cholesterol acyltransferase inhibitor F 12511 in casein-fed New Zealand rabbits. J. Cardiovasc. Pharmacol. (2002) 39(2):181-191.
    • (2002) J. Cardiovasc. Pharmacol , vol.39 , Issue.2 , pp. 181-191
    • Rival, Y.1    Junquero, D.2    Bruniquel, F.3
  • 35
    • 0032126266 scopus 로고    scopus 로고
    • HMG-CoA reductase and ACAT inhibitors act synergistically to lower plasma cholesterol and limit atherosclerotic lesion development in the cholesterol-fed rabbit
    • BOCAN TMA, MUELLER SB, BROWN EQ et al: HMG-CoA reductase and ACAT inhibitors act synergistically to lower plasma cholesterol and limit atherosclerotic lesion development in the cholesterol-fed rabbit. Atherosclerosis (1998) 139(1):21-30.
    • (1998) Atherosclerosis , vol.139 , Issue.1 , pp. 21-30
    • Bocan, T.M.A.1    Mueller, S.B.2    Brown, E.Q.3
  • 36
    • 0035116435 scopus 로고    scopus 로고
    • F 12511, a novel ACAT inhibitor, and atorvastatin regulate endogenous hypercholesterolemia in a synergistic manner in New Zealand rabbits fed a casein-enriched diet
    • JUNQUERO D, BRUNIQUEL F, N'GUYEN X et al: F 12511, a novel ACAT inhibitor, and atorvastatin regulate endogenous hypercholesterolemia in a synergistic manner in New Zealand rabbits fed a casein-enriched diet. Atherosclerosis (2001) 155(1):131-142.
    • (2001) Atherosclerosis , vol.155 , Issue.1 , pp. 131-142
    • Junquero, D.1    Bruniquel, F.2    N'Guyen, X.3
  • 37
    • 0034971344 scopus 로고    scopus 로고
    • Inhibition of both ACAT and HMG-CoA reductase may directly induce atherosclerotic lesion regression
    • BOCAN TMA, KRAUSE BR, ROSEBURY WS et al.: Inhibition of both ACAT and HMG-CoA reductase may directly induce atherosclerotic lesion regression. Atherosclerosis (2001) 157(1):97-105.
    • (2001) Atherosclerosis , vol.157 , Issue.1 , pp. 97-105
    • Bocan, T.M.A.1    Krause, B.R.2    Rosebury, W.S.3
  • 38
    • 0000298868 scopus 로고    scopus 로고
    • Serial evaluation of atherosclerosis with in vivo MRI: Study of atorvastatin and avasimibe in WHHL rabbits
    • WORTHLEY SG, HELFT G, OSENDE JI et al.: Serial evaluation of atherosclerosis with in vivo MRI: Study of atorvastatin and avasimibe in WHHL rabbits. Circulation (2000)102:II809.
    • (2000) Circulation , vol.102
    • Worthley, S.G.1    Helft, G.2    Osende, J.I.3
  • 39
    • 0028964742 scopus 로고
    • Cell toxicity induced by inhibition of acyl coenzyme A: Cholesterol acyltransferase and accumulation of unesterified cholesterol
    • WARNER GJ, STOUDT G, BAMBERGER M et al: Cell toxicity induced by inhibition of acyl coenzyme A: cholesterol acyltransferase and accumulation of unesterified cholesterol. J. Biol. Chem. (1995) 270:5772-5778.
    • (1995) J. Biol. Chem , vol.270 , pp. 5772-5778
    • Warner, G.J.1    Stoudt, G.2    Bamberger, M.3
  • 40
    • 0031943893 scopus 로고    scopus 로고
    • Effects of intracellular free cholesterol accumulation on macrophage viability, a model for foam cell death
    • KELLNER-WEIBEL G, JERONE WG, SMALL DM et al.: Effects of intracellular free cholesterol accumulation on macrophage viability, a model for foam cell death. Arterioscler. Thromb. Vasc. Biol. (1998)18:423-431.
    • (1998) Arterioscler. Thromb. Vasc. Biol , vol.18 , pp. 423-431
    • Kellner-Weibel, G.1    Jerone, W.G.2    Small, D.M.3
  • 41
    • 0032868510 scopus 로고    scopus 로고
    • Novel effects of the acyl-coenzyme A: Cholesterol acyltransferase inhibitor 58-035 on foam cell development in primary human monocyte-derived macrophages
    • RODRIGUEZ A, BACHORIK PS, WEE SB: Novel effects of the acyl-coenzyme A: cholesterol acyltransferase inhibitor 58-035 on foam cell development in primary human monocyte-derived macrophages. Arterioscler. Thromb. Vasc. Biol. (1999)19:2199-2206.
    • (1999) Arterioscler. Thromb. Vasc. Biol , vol.19 , pp. 2199-2206
    • Rodriguez, A.1    Bachorik, P.S.2    Wee, S.B.3
  • 42
    • 0001569096 scopus 로고    scopus 로고
    • The acyl-CoA: Cholesterol acyltransferase inhibitor, avasimibe, effectively limits lipid storage in human macrophages
    • RODRIGUEZ A, WEE SK, USHER DC: The acyl-CoA: cholesterol acyltransferase inhibitor, avasimibe, effectively limits lipid storage in human macrophages. Circulation (1999) 100:613.
    • (1999) Circulation , vol.100 , pp. 613
    • Rodriguez, A.1    Wee, S.K.2    Usher, D.C.3
  • 43
    • 0030273663 scopus 로고    scopus 로고
    • Difference between normal and WHHL rabbits in susceptibility to the adrenal toxicity of an acyl-CoA:cholesterol acyltransferase inhibitor, FR 145237
    • MATSUO M, HASHIMOTO M, SUZUKI J, IWANAMI K, TOMOI M, SHIMOMURA K: Difference between normal and WHHL rabbits in susceptibility to the adrenal toxicity of an acyl-CoA:cholesterol acyltransferase inhibitor, FR 145237. Toxicol. Appl. Pharmacol. (1996) 140(2):387-392.
    • (1996) Toxicol. Appl. Pharmacol , vol.140 , Issue.2 , pp. 387-392
    • Matsuo, M.1    Hashimoto, M.2    Suzuki, J.3    Iwanami, K.4    Tomoi, M.5    Shimomura, K.6
  • 44
    • 0035865448 scopus 로고    scopus 로고
    • Lack of toxic effects of F 12511, a novel potent inhibitor of acyl-coenzyme A: Cholesterol O-acyltransferase, on human adrenocortical cells in culture
    • JUNQUERO D, PILON A, CARILLA-DURAND E et al.: Lack of toxic effects of F 12511, a novel potent inhibitor of acyl-coenzyme A: cholesterol O-acyltransferase, on human adrenocortical cells in culture. Biochem. Pharmacol. (2001) 61(4):387-398.
    • (2001) Biochem. Pharmacol , vol.61 , Issue.4 , pp. 387-398
    • Junquero, D.1    Pilon, A.2    Carilla-Durand, E.3
  • 45
    • 15644364732 scopus 로고    scopus 로고
    • Alpha-substituted malonester amides: Tools to define the relationship between ACAT inhibition and adrenal toxicity
    • SLISKOVIC DR, PICARD JA, O'BRIEN PM et al.: Alpha-substituted malonester amides: tools to define the relationship between ACAT inhibition and adrenal toxicity. J. Med. Chem. (1998) 41(5):682-690.
    • (1998) J. Med. Chem , vol.41 , Issue.5 , pp. 682-690
    • Sliskovic, D.R.1    Picard, J.A.2    O'Brien, P.M.3
  • 46
    • 0032539756 scopus 로고    scopus 로고
    • Biochemical evidence for oligomerization of rat adrenal acyl-coenzyme A:cholesterol acyltransferase
    • KAWASAKI T, MIYAZAKI A, HAKAMATA H, MATSUDA H, HORIUCHI S: Biochemical evidence for oligomerization of rat adrenal acyl-coenzyme A:cholesterol acyltransferase. Biochem. Biophys. Res. Commun. (1998) 244(2):347-352.
    • (1998) Biochem. Biophys. Res. Commun , vol.244 , Issue.2 , pp. 347-352
    • Kawasaki, T.1    Miyazaki, A.2    Hakamata, H.3    Matsuda, H.4    Horiuchi, S.5
  • 47
    • 0035124368 scopus 로고    scopus 로고
    • Preclinical safety evaluation of avasimibe in beagle dogs: An ACAT inhibitor with minimal adrenal effects
    • ROBERTSON DG, BREIDER MA, MILAD MA: Preclinical safety evaluation of avasimibe in beagle dogs: An ACAT inhibitor with minimal adrenal effects. Toxicol. Sci. (2001) 59:324-334.
    • (2001) Toxicol. Sci , vol.59 , pp. 324-334
    • Robertson, D.G.1    Breider, M.A.2    Milad, M.A.3
  • 49
    • 0034965751 scopus 로고    scopus 로고
    • Efficacy and short-term safety of a new ACAT inhibitor, avasimibe, on lipids, lipoproteins, and apolipoproteins, in patients with combined hyperlipidemia
    • INSULL W, KOREN M, DAVIGNON J et al.: Efficacy and short-term safety of a new ACAT inhibitor, avasimibe, on lipids, lipoproteins, and apolipoproteins, in patients with combined hyperlipidemia. Atherosclerosis (2001) 157:137-144.
    • (2001) Atherosclerosis , vol.157 , pp. 137-144
    • Insull, W.1    Koren, M.2    Davignon, J.3
  • 50
    • 0034023061 scopus 로고    scopus 로고
    • Massive xanthomatosis and altered composition of atherosclerotic lesions in hyperlipidemic mice lacking acyl CoA:cholesterol acyltransferase
    • ACCAD M, SMITH SJ, NEWLAND DL et al.: Massive xanthomatosis and altered composition of atherosclerotic lesions in hyperlipidemic mice lacking acyl CoA:cholesterol acyltransferase. J. Clin. Invest. (2000) 105(6):711-719.
    • (2000) J. Clin. Invest , vol.105 , Issue.6 , pp. 711-719
    • Accad, M.1    Smith, S.J.2    Newland, D.L.3
  • 51
    • 0035096678 scopus 로고    scopus 로고
    • Preferential pharmacological inhibition of macrophage ACAT increases plaque formation in mouse and rabbit models of atherogenesis
    • PERRY S, LEGENDRE C, MATSUURA A et al.: Preferential pharmacological inhibition of macrophage ACAT increases plaque formation in mouse and rabbit models of atherogenesis. Atherosclerosis (2001) 155(2):359-370.
    • (2001) Atherosclerosis , vol.155 , Issue.2 , pp. 359-370
    • Perry, S.1    Legendre, C.2    Matsuura, A.3
  • 53
    • 0034795651 scopus 로고    scopus 로고
    • Acyl-coenzyme A: Cholesterol acyltransferase modulates the generation of the anyloid beta-peptide
    • PUGLIELLI L, KONOPKA G, PACKCHUNG E et al.: Acyl-coenzyme A: cholesterol acyltransferase modulates the generation of the anyloid beta-peptide. Nat. Cell Biol. (2001) 10:905-912.
    • (2001) Nat. Cell Biol , vol.10 , pp. 905-912
    • Puglielli, L.1    Konopka, G.2    Packchung, E.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.